cancer
Targeting gut bacteria or butyrate could be a promising therapy for glioma.
Three promising bacteria were linked to better treatment responses in melanoma patients.
A recent study highlights formate as a potential target to boost cancer treatment.
Dietary intervention and the utilization of D. dubosii offer potential insights for the treatment of brain tumor patients.
New funding boosts development of microbiome-based therapies for hereditary cancer risk, opening paths to alternatives beyond surgery.
With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.
Targeting the gut microbiota could help predict, prevent or reduce chemotherapy-related toxicity.
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.
